Starlight Therapeutic is an emerging precision oncology company focused solely on CNS (central nervous system) cancers, primarily brain cancers.
It is estimated that there are over 120 subtypes of CNS cancers that have a devastating impact on adult and pediatric populations. Most of these CNS cancers do not have effective therapies and current treatment relies on a combination of surgery, radiotherapy, and chemotherapy. There is a significant need for new therapeutic options to improve patient outcomes. Starlight is developing our lead drug candidate, known as STAR-001, for some of the most unaddressed brain cancers. STAR-001, we believe, has the potential to be effective in both primary and secondary (metastatic) brain cancers as demonstrated in multiple preclinical cancer models.
Starlight’s initial focus is developing STAR-001 for CNS cancers including adult glioblastoma, adult brain metastases, and pediatric brain cancers such as atypical teratoid rhabdoid tumors (ATRT).
Company Details
- Address
- 7700 Windrose Ave, Plano,texas 75024,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://starlightthera.com
- Keywords
- Brain cancer research, CNS cancer research, Clinical Trials, Clinical Development, Biotechnology, Cancer Drug Development, Oncology, Precision medicine, Biomarkers, Genetic Screen, Precision Oncology.
- HQ
- Plano, Texas
Starlight Therapeutics Questions
Starlight Therapeutics's website is http://starlightthera.com
Starlight Therapeutics's LinkedIn profile is https://www.linkedin.com/company/starlightthera
Starlight Therapeutics's industry is
Biotechnology Research
Starlight Therapeutics's top competitors are
Vyant Bio,
Neutron Therapeutics Llc,
Lantern Pharma Inc. (Nasdaq: Ltrn),
Biontx,
Biolabs Pegasus Park - North Texas,
Taysha Gene Therapies,
Acadia Pharmaceuticals Inc.,
Nanoscope Therapeutics Inc.,
Gradalis, Inc.,
Immunesensor Therapeutics.
Starlight Therapeutics's categories are Biotechnology Research
